Amgen

Amgen jumps 5% on $5 billion stock buy-back
Marketwatch
Mon, 11/7/11 - 11:55 am
Amgen
stock buyback
Treatment With Enbrel® (etanercept) Shows Significant and Sustained Clinical Benefits in Rheumatoid Arthritis (RA) Patients With Moderately Active Disease
Yahoo/PR NewsWire
Sun, 11/6/11 - 12:01 pm
Enbrel
Amgen
rheumatoid arthritis
Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial
Yahoo/PR NewsWire
Sun, 11/6/11 - 12:00 pm
Prolia
osteoporosis
Amgen
Amgen Is A Bargain At These Levels
Seeking Alpha
Thu, 11/3/11 - 12:33 pm
Amgen
1 Reason the Street Should Love Amgen's Earnings
Motley Fool
Mon, 10/31/11 - 11:28 am
earnings
Amgen
Amgen Is Poised For Continued Success
Seeking Alpha
Wed, 10/26/11 - 09:08 am
Amgen
Pharmasset
Dendreon
Amgen Says it Set Aside $780 Million to Settle Drug Sale Kickback Claims
Bloomberg
Tue, 10/25/11 - 12:38 pm
kickbacks
Amgen
Aranesp
Baker's Dozen Trying To Beat The Odds In Pancreatic Cancer
Seeking Alpha
Tue, 10/25/11 - 10:49 am
pancreatic cancer
Amgen
Celgene
Infinity
Oncolytics
Pharmacyclics
Immunomedics
Threshold Pharmaceuticals
Clovis Oncology
Novartis
Aduro BioTech
NewLink Genetics
Seattle Genetics
Bayer Schering
Astellas
Amgen Third-Quarter Profit Beats Estimates on Higher Sales of Cancer Drugs
Bloomberg
Mon, 10/24/11 - 10:38 pm
earnings
Amgen
Which Drugmakers Have Overpaid CEOs?
Pharmalot
Mon, 10/24/11 - 11:07 am
executive pay
Pharma CEOs
Amgen
JNJ
Abbott Laboratories
Miles White
Kevin Sharer
William Weldon
Amgen Leads Firms In Pancreatic Cancer Drug Chase
InvestorPlace
Sun, 10/23/11 - 10:54 am
Amgen
Ganitumab
pancreatic cancer
Abbott May Be Doing The Right Thing At The Wrong Time
Seeking Alpha
Fri, 10/21/11 - 09:57 am
Abbott Laboratories
reorganization
Amgen
Biogen Idec
Bristol-Myers Squibb
GSK
JNJ
Boston Scientific
Medtronic
Pfizer
Roche
Pharmasset
Amgen 3Q report to focus on key drug sales trends
Yahoo/AP
Fri, 10/21/11 - 09:55 am
earnings
Amgen
Amgen To Lay Off Nearly 400 Employees
Pharmalot
Thu, 10/20/11 - 09:09 am
Amgen
layoffs
Earnings Preview: Amgen
Forbes
Wed, 10/19/11 - 05:38 pm
Amgen
earnings
The 8 Highest Potential Returns in Biotechnology
Motley Fool
Mon, 10/17/11 - 07:33 pm
Biomarin
Emergent BioSolutions
United Therapeutics
Gilead
3SBio
Targacept
Amgen
Celgene
Top Mid- And Large-Cap Biotech Picks By Legendary Fund Managers
Seeking Alpha
Fri, 10/14/11 - 11:41 am
Alexion
Amgen
Amylin
Biogen Idec
Biomarin
Celgene
Gilead
Human Genome Sciences
Incyte
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Theravance
5 promising pancreatic cancer drugs
Fierce Biotech
Thu, 10/13/11 - 01:23 pm
Amgen
Takeda
Ganitumab
KAEL-GemVax
GV1001
HyperAcute Pancreas
NewLink Genetics
GI-4000
GlobeImmune
MM-398
Merrimack Pharmaceuticals
pancreatic cancer
The Disconnect Continues: Amgen Rethinks R&D
Pharmalot
Thu, 10/13/11 - 11:31 am
Amgen
R&D
Johnson & Johnson Third Quarter Earnings Sneak Peek
Yahoo/Wall St. Cheat Sheet
Thu, 10/13/11 - 10:57 am
earnings
JNJ
Amgen
Abbott Laboratories
Boston Scientific

Pages